For instance, Wang et al14 and Huang et al22 reported that AKR1C2 functioned as an oncogene in human prostate cancer whereas Ji et al11 obtained opposing results, supporting that AKR1C2 acted as a tumour suppressor gene in human prostate cancer. This evidence concerns the gene AKR1C2 and prostate carcinoma.